TIVA with Propofol and Fentanyl for Spinal Decompression with IONM
Yes, TIVA with propofol and fentanyl is appropriate and recommended for this patient undergoing T6-L1 spinal decompression with IONM, with specific protocol modifications to optimize neuromonitoring and manage hypertension. 1, 2, 3
Recommended TIVA Protocol
Use propofol target-controlled infusion (effect-site target 0.5-1 mcg/mL) combined with remifentanil infusion (0.05-0.3 mcg/kg/min) rather than intermittent fentanyl boluses for this prolonged spine surgery with IONM. 1, 2 This approach provides superior hemodynamic stability and facilitates neuromonitoring compared to traditional fentanyl bolusing. 4, 5
Induction Protocol
- Propofol via TCI at effect-site concentration 0.5-1 mcg/mL, avoiding bolus dosing to prevent hemodynamic instability in this hypertensive patient. 1, 2
- Rocuronium 0.9-1.2 mg/kg for intubation (or succinylcholine 1-2 mg/kg as alternative). 1, 2
- Establish invasive arterial blood pressure monitoring before induction when feasible, with vasopressors immediately available (ephedrine or metaraminol). 1, 3 This is particularly important given the patient's hypertension managed with losartan, as propofol decreases cardiac output and systemic vascular resistance in a dose-dependent manner. 3
Maintenance Strategy
Propofol TCI at 0.5-1 mcg/mL combined with remifentanil 0.05-0.3 mcg/kg/min provides optimal conditions for IONM while reducing propofol requirements by approximately 30%. 1, 4 If using fentanyl instead of remifentanil, administer 0.5-1.0 mcg/kg boluses titrated to effect, but recognize this provides less stable analgesia for prolonged procedures. 1, 3
Consider adding dexmedetomidine (0.5-1 mcg/kg bolus then 0.2-0.7 mcg/kg/h) and ketamine (0.5 mg/kg bolus followed by 0.1-0.2 mg/kg/h) to further reduce propofol requirements and improve postoperative analgesia. 1 This multimodal approach is specifically recommended for 4-6 hour endoscopic spine surgery to minimize intraoperative hypotension and postoperative pain. 1
Critical Monitoring Requirements for IONM
Maintain BIS between 40-60 throughout the procedure to prevent awareness while avoiding excessive depth that could impair neuromonitoring. 1, 3 Propofol-based TIVA is superior to volatile anesthetics for IONM because it produces less suppression of motor evoked potentials. 4, 5
Standard monitoring must include:
- Continuous pulse oximetry and waveform capnography 3
- ECG and non-invasive blood pressure measured at least every 5 minutes 3
- Core temperature monitoring 3
- Quantitative neuromuscular monitoring if muscle relaxants used, documenting train-of-four ratio ≥0.90 before extubation 1, 2, 3
Hypertension Management Considerations
The patient's baseline hypertension managed with losartan requires specific attention. 6 Propofol increases vasopressor requirements in hemodynamically challenged patients, and the combination with opioids can cause significant hypotension. 6, 3 Have vasopressors immediately available and consider continuing the patient's morning losartan dose on the day of surgery with a small sip of water, though this should be coordinated with the surgical team. 6
Avoid simultaneous neuraxial and general anesthesia, as this combination is associated with precipitous intraoperative blood pressure falls. 6, 3 For this extensive T6-L1 decompression, general anesthesia alone is appropriate.
Critical Pitfalls to Avoid
Never use nitrous oxide, as it increases postoperative nausea/vomiting and may interfere with neuromonitoring. 2, 3
Do not use propofol if the patient has egg, soy, or sulfite allergies (propofol contains 10% soybean oil and 1.2% purified egg phosphatide). 3
Avoid bolus dosing of propofol or remifentanil during maintenance to prevent hemodynamic instability and respiratory depression. 1, 2, 3
Do not rely on opioid analgesics as the sole adjunct to anesthesia due to greater risk of respiratory depression and postoperative confusion. 6, 3
Adjunctive Medications
Administer dexamethasone 0.15-0.25 mg/kg (maximum 0.5 mg/kg) at induction to reduce postoperative swelling and inflammation. 1 For a 55kg patient, this would be 8.25-13.75 mg.
TIVA with propofol significantly reduces postoperative nausea and vomiting compared to volatile anesthetics. 1, 2
Emergence and Postoperative Management
Ensure complete return of airway reflexes and adequate tidal volumes before extubation, with the patient fully awake. 1, 3 Propofol has rapid clearance with predictable emergence. 3
For breakthrough pain in PACU, titrate fentanyl 0.5-1.0 mcg/kg to effect, with alternatives including morphine 25-100 mcg/kg or ketamine 0.25-0.5 mg/kg. 1
Transition to multimodal oral analgesia as soon as possible, with scheduled acetaminophen 10-15 mg/kg every 6 hours and scheduled NSAIDs if not contraindicated. 1 Reserve opioids for severe breakthrough pain only. 1
Evidence Supporting TIVA for Spine Surgery with IONM
Recent evidence demonstrates that dexmedetomidine as an adjuvant to propofol in TIVA reduces propofol requirements by approximately 30% without affecting IONM recordings, while ensuring stable hemodynamics and decreasing opioid requirements. 4 Additionally, dexmedetomidine displays superior efficacy in alleviating pain and postoperative pain management for 48 hours after spinal fusion compared to remifentanil alone. 5
Low-certainty evidence suggests TIVA may reduce postoperative cognitive dysfunction compared to inhalational anesthesia (OR 0.52,95% CI 0.31 to 0.87). 7 This is particularly relevant for maintaining optimal cognitive function for postoperative neurological assessment.